Skip to content
10-Q

Quarterly Report

ASTEX PHARMACEUTICALS, INC

0001047469-12-010321

← back to feed
Filed
Nov 9, 2012 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2012 · Nov 1, 2012 93.5M sh
Shares Diluted Q3 2012 · Sep 30, 2012 93.32M sh
Shares Diluted Q3 2012 · Sep 30, 2012 102.34M sh
Shares Diluted Q3 2012 · Sep 30, 2011 86.12M sh
Shares Diluted restated Q3 2012 · Sep 30, 2011 69.81M sh
Capex Q3 2012 · Sep 30, 2012 $872K
Capex Q3 2012 · Sep 30, 2011 $629K
Cash And Equivalents Q3 2012 · Sep 30, 2012 $26.77M
Cash And Equivalents Q3 2012 · Dec 31, 2011 $39.79M
Cash And Equivalents Q3 2012 · Sep 30, 2011 $37.94M
Cash And Equivalents Q3 2012 · Dec 31, 2010 $25.55M
Stockholders Equity Q3 2012 · Sep 30, 2012 $232.49M
Stockholders Equity Q3 2012 · Dec 31, 2011 $220M
Current Liabilities Q3 2012 · Sep 30, 2012 $24.33M
Current Liabilities Q3 2012 · Dec 31, 2011 $34.67M
Total Liabilities Q3 2012 · Sep 30, 2012 $37.43M
Total Liabilities Q3 2012 · Dec 31, 2011 $56.95M
Current Assets Q3 2012 · Sep 30, 2012 $139.04M
Current Assets Q3 2012 · Dec 31, 2011 $136.57M
Total Assets Q3 2012 · Sep 30, 2012 $269.91M
Total Assets Q3 2012 · Dec 31, 2011 $276.95M
Eps Diluted Q3 2012 · Sep 30, 2012 −$0.02
Eps Diluted Q3 2012 · Sep 30, 2012 $0.04
Eps Diluted Q3 2012 · Sep 30, 2011 −$0.01
Eps Diluted Q3 2012 · Sep 30, 2011 $0.08
Eps Basic Q3 2012 · Sep 30, 2012 −$0.02
Eps Basic Q3 2012 · Sep 30, 2012 $0.04
Eps Basic Q3 2012 · Sep 30, 2011 −$0.01
Eps Basic Q3 2012 · Sep 30, 2011 $0.08
Sga Expense Q3 2012 · Sep 30, 2012 $4.19M
Sga Expense Q3 2012 · Sep 30, 2012 $12.18M
Sga Expense Q3 2012 · Sep 30, 2011 $5.1M
Sga Expense Q3 2012 · Sep 30, 2011 $12.25M
Rd Expense Q3 2012 · Sep 30, 2012 $13.63M
Rd Expense Q3 2012 · Sep 30, 2012 $43.09M
Rd Expense Q3 2012 · Sep 30, 2011 $13.55M
Rd Expense Q3 2012 · Sep 30, 2011 $29.53M
Operating Income Q3 2012 · Sep 30, 2012 −$9.39M
Operating Income Q3 2012 · Sep 30, 2012 −$8.34M
Operating Income Q3 2012 · Sep 30, 2011 −$3.18M
Operating Income Q3 2012 · Sep 30, 2011 $3.15M
Revenue Q3 2012 · Sep 30, 2012 $17.19M
Revenue Q3 2012 · Sep 30, 2012 $59.1M
Revenue Q3 2012 · Sep 30, 2011 $16.95M
Revenue Q3 2012 · Sep 30, 2011 $45.71M